Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance
Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 14c, Offers Guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.44 | 52 Week High | $18.39 | |||
| Open | $108.44 | 52 Week Low | $6.96 | |||
| Day High | $108.44 | P/E | N/A | |||
| Day Low | $108.44 | EPS | $-0.58 | |||
| Volume | 44,889 | |||||

